Skip Navigation


International Immunology Advance Access originally published online on September 26, 2008
International Immunology 2008 20(11):1361-1368; doi:10.1093/intimm/dxn106
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
20/11/1361    most recent
dxn106v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (12)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Annunziato, F.
Right arrow Articles by Romagnani, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Annunziato, F.
Right arrow Articles by Romagnani, S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


© The Japanese Society for Immunology. 2008. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org

review-article

The phenotype of human Th17 cells and their precursors, the cytokines that mediate their differentiation and the role of Th17 cells in inflammation

Francesco Annunziato, Lorenzo Cosmi, Francesco Liotta, Enrico Maggi and Sergio Romagnani

Center of Excellence for Research, Transfer and High Education on Chronic, Inflammatory, Degenerative and Neoplastic Disorders for the Development of Novel Therapies, University of Florence, Florence, Italy

Correspondence to: S. Romagnani, Department of Internal Medicine, University of Florence, Viale Morgagni 85, Firenze 50134, Italy; E-mail: s.romagnani{at}dmi.unifi.it

T helper 17 (Th17) cells represent a new subset of CD4+ effector T cells which have been described in both mice and humans. However, some differences seem to exist between murine and human Th17 cells with regard to their features, origin and role in immunopathology. Murine Th17 cells share their developmental origin with Foxp3+ Treg cells, indeed naive T-cell precursors can be differentiated to regulatory T (Treg) cells by transforming growth factor-β (TGF-β) alone, whereas the contemporaneous presence of TGF-β and IL-6 gives origin to Th17 cells. Human Th17 cells which consistently express the CC chemokine receptor 6 and the equivalent of the murine NK1.1, CD161, appear to exclusively originate in response to IL-1β and IL-23 from a small subset of CD161+CD4+ T-cell precursors detectable in the thymus and in umbilical cord blood. These cells constitutively express the Th17-driving transcription factor retinoic acid-related orphan receptor (ROR){gamma}t and the IL-23R and can also give origin to Th1 cells or Th2 cells under the appropriate polarizing conditions. By contrast, human CD161-naive T cells only give rise to Th1 and Th2 cells, but not Th17 cells. TGF-β may not exert a direct critical role in human Th17 cell differentiation, but indirectly favours their development by inhibiting the development of Th1 cells, which are much more susceptible than Th17 cells to its suppressive activity on cell proliferation. Moreover, while murine Th17 are pathogenic in some murine models of autoimmunity where Th1 cells seem to play a protective role, both Th17 and Th1 certainly contribute to the pathogenesis of human autoimmune and other chronic inflammatory disorders.

Keywords: CD161, IL-1β, IL-23, ROR{gamma}t, TGF-β

Transmitting editor: H. Kikutani

Received 25 July 2008, accepted 28 August 2008.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 GutHome page
L Rovedatti, T Kudo, P Biancheri, M Sarra, C H Knowles, D S Rampton, G R Corazza, G Monteleone, A Di Sabatino, and T T MacDonald
Differential regulation of interleukin 17 and interferon {gamma} production in inflammatory bowel disease
Gut, December 1, 2009; 58(12): 1629 - 1636.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Gutermuth, K. E. Nograles, F. Miyagawa, E. Nelson, Y.-H. Cho, and S. I. Katz
Self-Peptides Prolong Survival in Murine Autoimmunity via Reduced IL-2/IL-7-Mediated STAT5 Signaling, CD8 Coreceptor, and V{alpha}2 Down-Regulation
J. Immunol., September 1, 2009; 183(5): 3130 - 3138.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
P. Miossec, T. Korn, and V. K. Kuchroo
Interleukin-17 and Type 17 Helper T Cells
N. Engl. J. Med., August 27, 2009; 361(9): 888 - 898.
[Full Text] [PDF]

Home page
 GutHome page
S Brand
Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease
Gut, August 1, 2009; 58(8): 1152 - 1167.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
E. Sanchez-Lopez, S. Rayego, R. Rodrigues-Diez, J. S. Rodriguez, R. Rodrigues-Diez, J. Rodriguez-Vita, G. Carvajal, L. S. Aroeira, R. Selgas, S. A. Mezzano, et al.
CTGF Promotes Inflammatory Cell Infiltration of the Renal Interstitium by Activating NF-{kappa}B
J. Am. Soc. Nephrol., July 1, 2009; 20(7): 1513 - 1526.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
A. Awasthi and V. K. Kuchroo
Th17 cells: from precursors to players in inflammation and infection
Int. Immunol., May 1, 2009; 21(5): 489 - 498.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.